Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Infarct angioplasty: beyond stents and glycoprotein IIb/IIIa inhibitors.

Literature DB >> 15919647

Infarct angioplasty: beyond stents and glycoprotein IIb/IIIa inhibitors.

S R Dixon¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2005 PMID： 15919647 PMCID： PMC1876359 DOI： 10.1136/hrt.2005.060251

Source DB: PubMed Journal: Heart ISSN： 1355-6037 Impact factor: 5.994

× No keyword cloud information.

32 in total

1. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.

Authors: Kai C Wollert; Gerd P Meyer; Joachim Lotz; Stefanie Ringes-Lichtenberg; Peter Lippolt; Christiane Breidenbach; Stephanie Fichtner; Thomas Korte; Burkhard Hornig; Diethelm Messinger; Lubomir Arseniev; Bernd Hertenstein; Arnold Ganser; Helmut Drexler
Journal: Lancet Date: 2004 Jul 10-16 Impact factor: 79.321

2. Feasibility of endovascular cooling as an adjunct to primary percutaneous coronary intervention (results of the LOWTEMP pilot study).

Authors: David E Kandzari; Alan Chu; Bruce R Brodie; Thomas A Stuckey; James B Hermiller; George W Vetrovec; Karen L Hannan; Mitchell W Krucoff; Robert H Christenson; Raymond J Gibbons; Kristina N Sigmon; Jyostna Garg; Victor Hasselblad; Kenneth Collins; Robert A Harrington; Peter B Berger; Nicholas A Chronos; Judith S Hochman; Robert M Califf
Journal: Am J Cardiol Date: 2004-03-01 Impact factor: 2.778

3. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial.

Authors: Volker Schächinger; Birgit Assmus; Martina B Britten; Jörg Honold; Ralf Lehmann; Claudius Teupe; Nasreddin D Abolmaali; Thomas J Vogl; Wolf-Karsten Hofmann; Hans Martin; Stefanie Dimmeler; Andreas M Zeiher
Journal: J Am Coll Cardiol Date: 2004-10-19 Impact factor: 24.094

4. Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction: a clinical and angiographic study.

Authors: Francesco Saia; Pedro A Lemos; Chi-Hang Lee; Chourmouzios A Arampatzis; Angela Hoye; Muzaffer Degertekin; Kengo Tanabe; Georgios Sianos; Pieter C Smits; Eugene McFadden; Sjoerd H Hofma; Willem J van der Giessen; Pim J de Feyter; Ron T van Domburg; Patrick W Serruys
Journal: Circulation Date: 2003-10-13 Impact factor: 29.690

5. Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction.

Authors: Pedro A Lemos; Francesco Saia; Sjoerd H Hofma; Joost Daemen; Andrew T L Ong; Chourmouzios A Arampatzis; Angela Hoye; Eugene McFadden; Georgios Sianos; Pieter C Smits; Willem J van der Giessen; Pim de Feyter; Ron T van Domburg; Patrick W Serruys
Journal: J Am Coll Cardiol Date: 2004-02-18 Impact factor: 24.094

Review 6. Hyperoxemic perfusion for treatment of reperfusion microvascular ischemia in patients with myocardial infarction.

Authors: Antonio L Bartorelli
Journal: Am J Cardiovasc Drugs Date: 2003 Impact factor: 3.571

7. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial.

Authors: Hyun-Jae Kang; Hyo-Soo Kim; Shu-Ying Zhang; Kyung-Woo Park; Hyun-Jai Cho; Bon-Kwon Koo; Yong-Jin Kim; Dong Soo Lee; Dae-Won Sohn; Kyou-Sup Han; Byung-Hee Oh; Myoung-Mook Lee; Young-Bae Park
Journal: Lancet Date: 2004-03-06 Impact factor: 79.321

8. Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial.

Authors: Christopher B Granger; Kenneth W Mahaffey; W Douglas Weaver; Pierre Theroux; Judith S Hochman; Thomas G Filloon; Scott Rollins; Thomas G Todaro; Jose C Nicolau; Witold Ruzyllo; Paul W Armstrong
Journal: Circulation Date: 2003-08-18 Impact factor: 29.690

9. The "no-reflow" phenomenon after temporary coronary occlusion in the dog.

Authors: R A Kloner; C E Ganote; R B Jennings
Journal: J Clin Invest Date: 1974-12 Impact factor: 14.808

10. Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial.

Authors: Iwan C C van der Horst; Felix Zijlstra; Arnoud W J van 't Hof; Carine J M Doggen; Menko-Jan de Boer; Harry Suryapranata; Jan C A Hoorntje; Jan-Henk E Dambrink; Rijk O B Gans; Henk J G Bilo
Journal: J Am Coll Cardiol Date: 2003-09-03 Impact factor: 24.094

3 in total

Review 1. Bench-to-bedside review: Hypothermia in traumatic brain injury.

Authors: H Louise Sinclair; Peter Jd Andrews
Journal: Crit Care Date: 2010-02-15 Impact factor: 9.097

2. Regional heterogeneity of myocardial reperfusion injury: effect of mild hypothermia.

Authors: Hirotsugu Hamamoto; Bradley G Leshnower; Landi M Parish; Hiroaki Sakamoto; Shinya Kanemoto; Robin Hinmon; Shinji Miyamoto; Joseph H Gorman; Robert C Gorman
Journal: Ann Thorac Surg Date: 2009-01 Impact factor: 4.330

3. European society of intensive care medicine study of therapeutic hypothermia (32-35 °C) for intracranial pressure reduction after traumatic brain injury (the Eurotherm3235Trial).

Authors: Peter J D Andrews; Helen Louise Sinclair; Claire G Battison; Kees H Polderman; Giuseppe Citerio; Luciana Mascia; Bridget A Harris; Gordon D Murray; Nino Stocchetti; David K Menon; Haleema Shakur; Daniel De Backer
Journal: Trials Date: 2011-01-12 Impact factor: 2.279

3 in total